Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1469 Articles

Chris Lange | Aug 2, 2016 at 9:05 AM EDT

Pfizer Earnings Fail to Impress Investors

When Pfizer reported its second-quarter financial results before the markets opened on Tuesday, investors initially did not appear impressed.

Chris Lange | Aug 1, 2016 at 11:25 AM EDT

What to Expect From Pfizer Earnings

The upcoming earnings report will showcase what Pfizer has to offer for the second half of 2016, and potentially give…

Chris Lange | Jul 31, 2016 at 10:50 AM EDT

The Top 10 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and other major companies reporting their quarterly results…

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Lee Jackson | Jul 16, 2016 at 9:15 AM EDT

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great…

Paul Ausick | Jul 14, 2016 at 4:01 PM EDT

Goldman Sachs, Apple Boost DJIA on Thursday

July 14, 2016: Markets opened higher again Thursday after producer prices came in higher than expected for June and new…

Jon C. Ogg | Jul 14, 2016 at 8:40 AM EDT

5 Companies Likely Buying Back the Most Stock in June and July

With many stocks having just hit record highs, investors need at least a bit of an explanation here. One thing…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Douglas A. McIntyre | Jul 9, 2016 at 9:25 AM EDT

Viagra Price Drops 50% as Drug Faces Competition

Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.

Lee Jackson | Jul 5, 2016 at 10:25 AM EDT

Jefferies Makes Major Change to Franchise Picks Stock Portfolio

Solid dividend-paying stocks make sense for the rest of this year. While it looks like the stress from the Brexit…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Paul Ausick | Jul 1, 2016 at 4:01 PM EDT

The 4 Stocks That Buoyed the DJIA on Friday

July 1, 2016: Markets opened higher down slightly Friday before climbing to mid-morning highs only to trail lower for much…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

Jon C. Ogg | Jun 23, 2016 at 8:05 AM EDT

20 Companies Buying Back the Most Stock in 2016

Standard & Poor's has now shown that the first quarter of 2016 saw a 12% rise in buyback spending to…

Paul Ausick | Jun 21, 2016 at 4:01 PM EDT

The 4 Stocks That Lifted the Dow on Tuesday

June 21, 2016: Markets opened higher again Tuesday ahead of Fed chairwoman Janet Yellen’s appearance on Capitol Hill. The odds…

1 … 46 47 48 49 50 … 98

Pfizer : PFE

All Pfizer Articles

Pfizer Earnings Fail to Impress Investors

What to Expect From Pfizer Earnings

The Top 10 Earnings for the Week Ahead

Short Sellers Get Selective on Major Pharma

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Goldman Sachs, Apple Boost DJIA on Thursday

5 Companies Likely Buying Back the Most Stock in June and July

Short Sellers Run for Cover From Major Pharma

Viagra Price Drops 50% as Drug Faces Competition

Jefferies Makes Major Change to Franchise Picks Stock Portfolio

How Major Pharma Is Faring After the Brexit

The 4 Stocks That Buoyed the DJIA on Friday

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

20 Companies Buying Back the Most Stock in 2016

The 4 Stocks That Lifted the Dow on Tuesday

The Money Guy Show: Buy Now, Pay Later Schemes Are Never Worth It

RBC Raises Price Target on Target to $132 Ahead of Q1: Is the Turnaround Finally Resonating?

Wall Street Just Piled Into Datadog: KeyBanc Hikes Price Target to $225 as AI Customer Wins Accelerate

The Money Guy Show: Buy Now, Pay Later Schemes Are Never Worth It

How to Build $3,000 a Month in Dividend Income

The Money Guy Show: Buy Now, Pay Later Schemes Are Never Worth It

RBC Raises Price Target on Target to $132 Ahead of Q1: Is the Turnaround Finally Resonating?

Pfizer : PFE

All Pfizer Articles

Pfizer Earnings Fail to Impress Investors

What to Expect From Pfizer Earnings

The Top 10 Earnings for the Week Ahead

Short Sellers Get Selective on Major Pharma

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Goldman Sachs, Apple Boost DJIA on Thursday

5 Companies Likely Buying Back the Most Stock in June and July

Short Sellers Run for Cover From Major Pharma

Viagra Price Drops 50% as Drug Faces Competition

Jefferies Makes Major Change to Franchise Picks Stock Portfolio

How Major Pharma Is Faring After the Brexit

The 4 Stocks That Buoyed the DJIA on Friday

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

20 Companies Buying Back the Most Stock in 2016

The 4 Stocks That Lifted the Dow on Tuesday

The Money Guy Show: Buy Now, Pay Later Schemes Are Never Worth It

RBC Raises Price Target on Target to $132 Ahead of Q1: Is the Turnaround Finally Resonating?

Wall Street Just Piled Into Datadog: KeyBanc Hikes Price Target to $225 as AI Customer Wins Accelerate

Featured Reads

The Money Guy Show: Buy Now, Pay Later Schemes Are Never Worth It

How to Build $3,000 a Month in Dividend Income